SCORR Marketing hires Dee Fuehrer

Monday, June 10, 2013 11:45 AM

SCORR Marketing has hired Dee Fuehrer, an expert in trade show and event planning for the life sciences industry, to lead its trade show marketing services team.

“Dee has more experience and knowledge about trade show marketing in the drug development sector than anyone in the industry,” said Cinda Orr, SCORR Marketing president and chief executive officer.

Fuehrer has developed strategy, managed budgets, coordinated logistics and executed hundreds of exhibits and conferences all over the world as a trade show and events manager for companies in the life sciences industry for more than 20 years. She also has the distinction of Certified Trade Show Marketer (CTSM), offered in affiliation with Northern Illinois University Outreach and reflecting adherence to the highest standards.

Fuehrer has served on the Exhibitor Advisory Committee for the Drug Information Association (DIA) for the past year. Fuehrer’s opinions and ideas help give direction on how to improve future DIA events.

“Dee and I worked together when I was vice president of global marketing for MDS Pharma Services, and I believe no one is more qualified to advise life science companies on how to develop effective strategies and generate qualified leads,” Orr said. ”We are confident she will be a valuable asset for our clients.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs